Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Tumor Mutations and VTE Risk – New Insights from a 12,500-Patient Cancer Study – JTH
Apr 6, 2026, 16:34

Tumor Mutations and VTE Risk – New Insights from a 12,500-Patient Cancer Study – JTH

Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Naomi Cornish et al, adding:

”Associations of Tumor Somatic Mutations with Cancer-Associated Venous Thromboembolism

Analysis of 12,507 cancer patients reveals that somatic mutations in CDKN2A, KRAS, PCDH15, and TP53 significantly increase VTE risk, while high tumor mutational burden is protective, offering novel insights into cancer-associated thrombosis pathophysiology and future risk prediction tools.”

Title: Associations of tumor somatic mutations with cancer-associated venous thromboembolism

Authors: Naomi Cornish, Rebecca Ward, Matthew T. Warkentin, Chrissie Thirlwell, Andrew D. Mumford, Sarah K. Westbury, Philip C. Haycock

Read the Full Article on JTH

Tumor Mutations and VTE Risk - New Insights from a 12,500-Patient Cancer Study - JTH

Stay updated on all scientific advances with Hemostasis Today.